Intra-patient and inter-metastasis heterogeneity of HER2-low status in metastatic breast cancer
Tatjana Geukens(VIB-KU Leuven Center for Cancer Biology), Christine Desmedt(Université Libre de Bruxelles)
Cited by 58
Related Papers
Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
|Nature Communications|2017|190
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium
|Modern Pathology|2024|27
Expression of antibody-drug conjugate targets in post-mortem samples of breast cancer metastases and normal tissue
|Nature Communications|2025|0